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Abstract  12 
 13 
Tennis elbow or lateral epicondylalgia is a diagnosis familiar to many 14 
within the general community and presents with an uncomplicated 15 
clinical picture in most cases. However, the underlying 16 
pathophysiology presents a more complex state and its management 17 
has not been conclusively determined.  Research on this topic extends 18 
across anatomical, biomechanical and clinical literature, however 19 
integration of findings is lacking. We propose that the current 20 
understanding of the underlying pathophysiology of lateral 21 
epicondylalgia can be conceptualised as encompassing three 22 
interrelated components: (i) the local tendon pathology, (ii) changes in 23 
the pain system, and (iii) motor system impairments. This paper 24 
presents a model that integrates these components on the basis of a 25 
literature review with the express aim of assisting in the targeting of 26 
specific treatments or combinations thereof to individual patients.  27 
 28 
29 
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INTRODUCTION 30 
Pain over the lateral epicondyle associated with gripping and 31 
manipulation of the hand is generally linked with a diagnosis of tennis 32 
elbow or lateral epicondylalgia (LE). With an annual incidence of 4 to 33 
7 cases per 1000 patients in general practice [1, 2] and 1-3% within 34 
the general population [3-7], LE is a common condition that 35 
significantly impacts on the individual and society. It occurs primarily 36 
between the ages of 35 and 54 years, and typically affects the 37 
dominant arm in men and women alike.[1, 2, 7] Tennis players [8] and 38 
those working in industries requiring manual tasks with a combination 39 
of force, repetition and poor posture are at greater risk.[7, 9, 10] 40 
 41 
LE is commonly recognised as being challenging to treat and prone to 42 
recurrent episodes. The average duration of a typical episode ranges 43 
from 6 to 24 months, with most patients (89%) reporting recovery by 44 
one year.[1] High recurrence rates have been reported with 45 
corticosteroid injection, a common conservative treatment of LE. In a 46 
recent randomised controlled trial, 72% of patients reported a 47 
recurrence in their condition within twelve months of receiving a 48 
corticosteroid injection in comparison to 9% with a “wait and see” 49 
policy.[11] It has been estimated that between 5-10% of patients 50 
develop chronic symptoms and eventually undergo surgical 51 
intervention.[12-15]  52 
 53 
The clinical presentation of LE is reasonably straightforward and easy 54 
to recognise, which contrasts to a more complex underlying 55 
pathophysiology. Whilst our knowledge of clinically effective 56 
treatments is increasingly evidence based, the challenge for the 57 
healthcare practitioner, whether in clinic or the laboratory, is to 58 
reconcile this to emerging findings of the condition’s 59 
pathophysiology. This paper provides a synopsis of the current 60 
evidence of the pathology of LE and proposes a model that seeks to 61 
reconcile this evidence with emerging best practice strategies in the 62 
management of the condition. 63 
 64 
A PROPOSED PATHOPHYSIOLOGICAL MODEL OF 65 
LATERAL EPICONDYLALGIA  66 
A new model is proposed to assist integration of current evidence of 67 
LE’s pathophysiology with the purpose of providing a better rationale 68 
for emerging management strategies. We propose that LE can be 69 
conceptualised as comprising three interrelated components: (i) the 70 
local tendon pathology, (ii) changes in the pain system, and (iii) 71 
impairment in the motor system (Figure 1). In this model it is 72 
recognised that not all LE patients have the same clinical presentation.  73 
It is proposed that through comprehensive evaluation, different 74 
proportions of tendon pathology, pain system dysfunction and motor 75 
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system impairments can be used to define subgroups of LE in the 76 
clinic and research laboratory. This will assist in the matching of 77 
individual patient presentations to effective treatment approaches.   78 
 79 
<<< insert Figure 1 here>>> 80 
EVIDENCE OF LOCAL TENDON PATHOLOGY 81 
Similar tendon changes have been identified in LE, Achilles and 82 
patellar tendinopathies, suggestive of a consistent underlying 83 
process.[16] Microscopic and histological analyses of affected tendons 84 
have identified four key changes, collectively termed 85 
angiofibroblastic hyperplasia: (1) increased cell numbers and ground 86 
substance; (2) vascular hyperplasia or neovascularisation; (3) 87 
increased concentration of neurochemicals and (4) disorganised and 88 
immature collagen.[17-19] Consistent absence of inflammatory cells 89 
has resulted in the general consensus that the process is non-90 
inflammatory in nature, although neurogenic inflammation may play a 91 
role.[19, 20] Instead, the pathological process has been described as 92 
‘degenerative’, or one of ‘dysfunctional, immature healing’. [17, 18, 93 
21] A continuum of tendon cellular and structural changes has been 94 
recently proposed to occur in tendinopathy accounting for 95 
heterogeneity of presentation.[22] Neovessel ingrowth has recently 96 
received increased attention as a source of pain in LE, owing to the 97 
close association between neural structures, microvasculature and 98 
neurochemicals at the proximal tendinous insertion of extensor carpi 99 
radialis brevis (ECRB).[23-25]   100 
 101 
Tendons are a living tissue and respond to mechanical forces by 102 
altering their structure, composition and mechanical properties, a 103 
process referred to as mechanotransduction.[22, 26-29] Physical 104 
training promotes both synthesis and degradation of collagen with a 105 
dominance of the former process, resulting in increased Type I 106 
collagen.[29, 30] Stress-deprivation adversely affects tendons, 107 
resulting in increased fibroblasts, decreased longitudinally aligned 108 
collagen, decreased tendon stiffness and tensile strength.[29, 31] 109 
altered gene expression, imbalance of matrix metalloproteinases, a 110 
group of enzymes involved in remodeling of the extracellular matrix, 111 
and growth factors are currently being studied to better understand the 112 
dynamic response of tendon to mechanical loading.[32] 113 
 114 
LE is traditionally described as an overuse injury, where the ability of 115 
the tendon to repair itself becomes overwhelmed, leading to micro- 116 
and macroscopic changes.[17, 19, 33] however, recent studies of 117 
patellar and achilles tendons have identified lower strain levels in the 118 
deeper regions of the tendon associated with tendinopathic change. 119 
[34, 35] It was suggested that stress-shielding, a term used to describe 120 
the tissue experiencing lower strain levels, may predispose specific 121 
regions of the tendon to structural weakening, making it more 122 
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susceptible to overload.[22, 27, 36, 37] It has also been argued that 123 
insertional tendinopathies may not be purely tensile injuries, but that 124 
compressive and shear forces may be involved.[21, 38, 39] The 125 
fibrocartilaginous composition of the ECRB enthesis may reflect a 126 
functional adaptation to these forces.[40]    127 
 128 
Pathological changes have been reported in the deep and anterior 129 
fibres of the proximal insertion of the ECRB tendon, defining LE as 130 
an ‘insertional tendinopathy’ or ‘enthesopathy’.[15, 18, 41, 42] An 131 
understanding of the unique structure and function of the extensor 132 
region of the elbow is useful for appreciation of pathology. The ECRB 133 
enthesis comprises a superficial, narrow attachment to the lateral 134 
epicondyle and a broad attachment to an intermuscular septum.[40, 135 
43] The deeper aspect merges directly with the lateral collateral 136 
ligament and indirectly with the annular ligament. The extensive 137 
connections of this enthesis are believed to be involved in the natural 138 
dissipation of stress across a broad area.[33, 40, 43] High levels of 139 
stress within the ECRB musculotendinous unit has been suggested as 140 
contributing to the overuse changes seen in LE.[44, 45] In summary, 141 
local tendon pathology may be the result of overuse, underuse, tensile, 142 
compressive or shear forces, which leave the tendon in a debilitated 143 
state. 144 
Diagnostic imaging of local pathology 145 
While LE is usually diagnosed clinically, recent research using 146 
imaging suggests that certain modalities may be helpful in diagnosing 147 
local tissue pathology. Ultrasound imaging has been used to identify 148 
grey-scale or structural changes in affected tendons in LE, including 149 
tendon thickening or thinning, focal areas of hypoechogenicity, 150 
tendon tears, calcification or bony irregularity.[42, 46-48] Tendon 151 
neovascularisation in LE has been detected with Doppler ultrasound 152 
and correlated with degenerative tissue on biopsy.[41, 47] 153 
Comparison of these two imaging modalities by du Doit et al. (2008), 154 
found neovascularity detected by power-Doppler to be diagnostically 155 
superior in identifying chronic LE compared to grey-scale changes.[47] 156 
The absence of both tendon neovascularity and grey-scale changes 157 
was shown to conclusively rule out LE as a diagnosis and should 158 
prompt further investigation.[47] However, the amount of 159 
neovascularity was not correlated with clinical measures of pain 160 
severity or function.[47] In summary, current evidence suggests that 161 
imaging is useful for confirmation of the diagnosis of LE and that 162 
neovascularity, but not structure might be related to clinical findings. 163 
There is currently no evidence to suggest that findings on imaging 164 
should dictate management of the condition or be used as an outcome 165 
measure.[39, 49] 166 
 167 
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EVIDENCE OF PAIN SYSTEM CHANGES  168 
In chronic musculoskeletal pain states such as LE, the patient’s pain 169 
experience may culminate from changes in both the peripheral and 170 
central nervous systems, possibly involving both nociceptive and non-171 
nociceptive processes as well as neuronal and non-neuronal tissues. 172 
We use the term ‘pain system changes’ to define this complex 173 
phenomenon. It is increasingly recognised that a disordered pain 174 
system itself may contribute to the pathophysiology of the 175 
condition.[24, 25, 50, 51]  Microdialysis of LE-affected tendons has 176 
demonstrated increased concentrations of glutamate.[20]  Substance P 177 
and calcitonin gene-related peptide reactive nerve fibres have been 178 
located in the proximal ECRB tendon in conjunction with small blood 179 
vessels.[23-25] These neurochemicals are known to be potent 180 
modulators of pain in the human nervous system, with additional roles 181 
in regulating the local tendon circulation and neurogenic 182 
inflammation.[19, 23-25, 50] 183 
 184 
Quantitative sensory testing has been used to better understand the 185 
pain processing mechanisms underlying LE symptoms. In brief, LE is 186 
typically characterised by hyperalgesia, defined as an exaggerated or 187 
increased response to a noxious stimulus.[52] Reduction in pressure 188 
pain thresholds by an average of 45-54% has been demonstrated over 189 
the lateral epicondyle of affected elbows compared to unaffected 190 
elbows of LE sufferers.[53-56] On comparison with a healthy control 191 
group, Slater et al (2005) demonstrated significant bilateral 192 
hyperalgesia in LE.[57]  It was suggested that transition from a 193 
unilateral localised pain to chronic LE with bilateral manifestations 194 
may be a time-dependent process. [57] Whilst thermal pain threshold 195 
is not affected in the majority of LE [54, 58], cold hyperalgesia was 196 
found in a subgroup of patients with chronic LE who responded to a 197 
regional block with guanethidine, that is, those with a component of 198 
sympathetically maintained chronic pain.[59]   199 
Secondary Hyperalgesia in Lateral Epicondylalgia   200 
A number of interacting neurophysiologic mechanisms may explain 201 
the hyperalgesia observed in LE. The presence of bilateral deficits in 202 
pain thresholds [57], along with bias towards mechanical rather than 203 
thermal hyperalgesia [51], is characteristic of secondary hyperalgesia. 204 
This implicates some form of altered processing within the neuraxis 205 
(spinal or supraspinal centres), often referred to as central 206 
sensitisation.[52] Extrapolation from other neurophysiological studies 207 
suggest that this process is initiated by activity in peripheral 208 
nociceptors, but may be sustained in the absence of peripheral 209 
nociceptor input.[52] Release of excitatory amino acids and 210 
neuropeptides, such as glutamate and Substance P from presynaptic 211 
nociceptive afferents may be involved in initiation of a cascade of 212 
changes that enhance the neuron’s responsiveness, which include 213 
increased excitability of wide-dynamic range neurons and increased 214 
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receptive field size.[52] Further supporting the involvement of this 215 
process in LE, is evidence of myelinated group A fibres mediating the 216 
reduced mechanical pain thresholds in LE.[51] 217 
 218 
A defining feature of secondary hyperalgesia is the spread of the 219 
reduced mechanical pain threshold beyond that of the original site of 220 
tissue injury.[52] This may explain how symptoms of LE can arise 221 
from tissues, such as the cervical spine and neural tissues, that are 222 
neurologically related to, but not at, the injured tissue site.[53, 60-64] 223 
Positive findings on manual examination of the cervical spine have 224 
been documented in 56% of LE sufferers.[61] Comparison with an 225 
age-matched control population, found a significantly higher 226 
prevalence of self-reported neck pain in LE participants, suggesting 227 
that degenerative and age-related changes do not sufficiently account 228 
for neck pain in people with LE.[60] Several studies have also 229 
reported positive radial nerve neurodynamic testing in LE 230 
participants.[54, 61, 62] The presence of concomitant neck pain has 231 
been associated with higher pain scores at 1 year follow-up[1], while 232 
female patients with nerve symptoms (pins and needles or numbness) 233 
were more likely to experience a poorer short-term outcome after 8 234 
weeks of physical therapy.[61]  235 
EVIDENCE OF MOTOR IMPAIRMENTS 236 
Evidence of dysfunction of the motor system has been demonstrated 237 
in LE, including diminished strength [56, 57, 65], morphological 238 
changes [66] and altered motor control.[67-70] Consistent with the 239 
pattern of impairments in the pain system, some of the motor system 240 
changes are apparent bilaterally [67, 71] and at both local and remote 241 
sites.[72]  242 
Deficits of gripping capacity  243 
The wrist extensors are strongly activated in a stabilising role to 244 
prevent wrist flexion during gripping activities.[33] Interestingly, 245 
pain-free grip is more sensitive to change than maximum grip 246 
strength, and is the recommended clinical outcome measure in 247 
LE.[73] Pain-free grip force is reduced in LE by an average of 43-248 
64% on comparison to unaffected side.[54, 55, 67, 74, 75] By 249 
definition, this measure reflects the amount of force required to first 250 
reproduce pain and as such it is an indirect measure of the pain 251 
system, rather than a measure of strength. Testing of maximal grip 252 
strength in LE participants has revealed differing results between 253 
studies with unilateral weakness [57], bilateral weakness [72] and no 254 
weakness [67] reported.  Unpublished data from the latter study 255 
showed that maximal grip strength testing reproduced an average pain 256 
intensity on visual analogue scale of 53 mm, indicating that this test in 257 
this population is strongly pain provocative (Bisset, L. and Vicenzino, 258 
B. unpublished data, 2006), further emphasising pain-free grip testing 259 
rather than maximum grip strength as an outcome measure.[73] 260 
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 261 
Specific muscle strength deficits 262 
Flexor and extensor strength deficits have been observed at the wrist 263 
and hand in LE participants compared to healthy controls [57, 72], 264 
with the exception of extension of the metacarpophalangeal joint.[72] 265 
It was suggested that LE sufferers may maintain or increase strength 266 
of the finger extensors to compensate for weakness in the wrist 267 
extensors.[72] Assessment of shoulder rotation strength identified 268 
weakness in LE participants, indicating the local and remote impact of 269 
the condition.[72] In a subsequent study, Alizadehkhaiyat (2007) 270 
assessed muscle function in participants with a history of LE who had 271 
been asymptomatic for at least 6 months.[70] Remaining weakness 272 
was demonstrated on all upper limb strength measures except for 273 
strength of muscles of the metacarpophalangeal joint, compared to 274 
control participants, indicating incomplete functional recovery despite 275 
attenuation of pain.[70] 276 
 277 
Morphological changes of muscle 278 
Morphological abnormalities have been identified in the ECRB 279 
muscle of patients with long standing LE.[66] These include moth-280 
eaten fibres, fibre necrosis and signs of muscle fibre regeneration as 281 
well as higher percentages of the fast twitch oxidative muscle fibre 282 
type.[66] These changes are consistent with the identified strength 283 
deficits and would likely contribute to ongoing motor system 284 
impairment. 285 
 286 
Motor control deficits 287 
Electromyographic activity of the forearm muscles has been studied 288 
during the backhand tennis stroke.[68] Activity within ECRB muscle 289 
in LE affected players was significantly lower during the early 290 
acceleration phase, while greater at ball impact compared to uninjured 291 
players. Recently, reduced activity of extensor carpi radialis (ECR) 292 
muscles was demonstrated in participants with LE, during isometric 293 
wrist extension [69] and gripping tasks,[72] implicating an endurance 294 
deficit. Follow up testing of participants with symptomatic recovery 295 
from LE revealed improved ECR activity, suggestive of a link 296 
between neuromuscular activity and symptoms.[70] Pain-related 297 
inhibition or fear of pain and further injury were suggested as 298 
underlying mechanisms, but no comment was made about the pain 299 
responses during testing.[72] 300 
 301 
Bilateral deficits in wrist position during gripping (11° less extension) 302 
[67] and bilateral impediments in reaction time and speed of 303 
movement with reaching tasks [67, 71] have been identified in 304 
unilateral LE, possibly reflecting a motor correlate to alterations in 305 
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central processing found in the pain system. Consistent with this is 306 
greater error in detection of movement found in affected elbows of 307 
participants with LE when compared to a healthy control group, and 308 
suggests that poorer proprioception may contribute to impairments in 309 
motor function.[76] The optimal wrist posture for maximal grip force 310 
in healthy adults is reported to be slight wrist extension [77-79], with 311 
wrist flexion reducing maximal force development according to 312 
proposed models of length-tension relationships at the wrist.[44] This 313 
may account for grip strength deficits found in some LE patients.  314 
 315 
HETEROGENEITY OF CLINICAL PRESENTATION 316 
The clinical presentation of LE varies between individuals and 317 
possibly over the time course of the disorder. We propose that the 318 
three model components discussed above do not occur in isolation and 319 
independently do not provide a complete explanation for a patient’s 320 
clinical presentation. Some patients with acute LE may exhibit 321 
increased involvement of the pain system, while others with more 322 
recalcitrant conditions, may present with marked local tendon 323 
pathology. It is our contention that health care practitioners should 324 
seek to identify the relative expression of local pathology, pain and 325 
motor system dysfunction in individual patients, so that treatment 326 
strategies may be better matched to the clinical presentation. 327 
 328 
CONSERVATIVE MANAGEMENT OF LE 329 
Ideally, management should involve the integration of the patient’s 330 
clinical presentation with the evidence base of treatment efficacy and 331 
the condition’s underlying pathophysiology. We propose that our 332 
model be used to aid in interpreting the evidence base in order to 333 
customise the management approach for each individual patient.  The 334 
following section will present a synopsis of the current evidence for 335 
conservative management of LE and highlight potential links to 336 
pathophysiological bases. Pharmacotherapy, electrophysical therapy, 337 
exercise and multi-modal therapy tend to be the main conservative 338 
management strategies for LE.    339 
 340 
Pharmacotherapy 341 
Pharmacotherapy may be prescribed to facilitate early symptomatic 342 
relief and indirectly, through reduced nociceptive input, may limit 343 
potential sensitisation processes and motor impairment.  344 
 345 
Corticosteroid injection is considered effective in terms of short-term 346 
relief of symptoms in LE, supported by level 1 evidence from multiple 347 
randomised controlled trials.[11, 80-82] However, poor long-term 348 
outcomes have been consistently reported following this treatment, 349 
[82-84] including evidence of greater use of pain-relieving medication 350 
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and significantly higher recurrence rates than physiotherapy.[11] The 351 
physiological basis for these positive and negative effects has been 352 
attributed to alterations in release of noxious chemicals [19, 23, 85]  353 
and inhibition of collagen and granulation tissue [23, 86] respectively. 354 
 355 
Polidocanol, an aliphatic non-ionised nitrogen-free surface anaesthetic 356 
that is used as a sclerosing agent [87], has been used in LE to 357 
predominantly target neovessels under ultrasound guidance.[88-90] 358 
Injection of polidocanol has been shown to be comparable to an 359 
injection of lidocaine and epinephrine in effecting an approximate 360 
34mm improvement in pain on visual analogue score (VAS) at 12-361 
months.[88] Considering this improvement is of similar magnitude to 362 
that of corticosteroid injection [11, 91, 92], further consideration 363 
should be given to evaluating their relative clinical efficacy, including 364 
recurrence rates.  365 
 366 
Pharmacology research has also focused on the role of various agents 367 
in stimulating tendon healing. The efficacy of topical application of 368 
nitric oxide patches in LE has been investigated in LE and other 369 
tendinopathies due to hypothesised effect on collagen and matrix 370 
synthesis.[93] A clinical trial with placebo comparison in LE, 371 
demonstrated a 21% greater effect than with exercise alone.[94] The 372 
major complications of this medication were headache, weakness, 373 
dizziness and skin irritation, with 12% discontinuing treatment due to 374 
side-effects.  Notably, the positive clinical effects of nitrous oxide 375 
patches were not supported in a recent dosing study [95] in which 376 
these patches were combined with stretching only  (not the 377 
concentric and eccentric exercises of the previous study [94]). 378 
 This appears to infer that the beneficial clinical effects of nitrous 379 
oxide patches in treating LE may be dependent upon the physical 380 
stimulus of specific concentric-eccentric exercise.  Preliminary case 381 
series studies of injection of autologous blood or platelet-rich plasma 382 
have reported positive effects on pain and patient satisfaction in LE, 383 
however no randomised clinical trials have been reported.[96-98]  384 
 385 
While the above pharmacological agents are promising, selectively 386 
treating those patients who present with a predominance of pain 387 
system involvement or with identifiable structural tendon pathology 388 
may enhance their effectiveness. We suggest that implementation of 389 
the model may be used by clinicians and researchers to match patient 390 
presentations with appropriate pharmacological agents. 391 
 392 
Electrophysical agents 393 
The efficacy of electrophysical agents in treatment of LE has been 394 
evaluated in a number of systematic reviews.[99-102] The rationale 395 
for their clinical use is generally attributed to either stimulation of soft 396 
tissue healing and/or inhibition of pain receptors.[99, 102] Bjordal et 397 
al (2008) recommend that low level laser therapy (LLLT) may be 398 
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considered as an alternative therapy to pharmacological agents in 399 
management of tennis elbow.[99] Meta-analysis of data from 10 trials 400 
found a significantly greater improvement in pain (VAS of 10.2mm) 401 
with LLLT over controls at the end of the treatment period. The 402 
narrowly defined regime of 908nm wavelength directly at the tendon 403 
site provided greater pain relief (17.2 mm (95% CI: 8.5 to 25.9) and 404 
RR of 1.53 (95% CI: 1.28 to 1.83) in the short term, which highlights 405 
the importance of considering specificity of dosing parameters. 406 
Currently there is no consensus on the use of shock wave therapy for 407 
this condition, owing to a lack of high quality trials and contradictory 408 
evidence between trials and between systematic reviews.[100, 102] 409 
Weak evidence was reported for the effectiveness of ultrasound in 410 
comparison to placebo on the basis of two small trials [103], while a 411 
recent study found no significant effects of this modality.[99, 104]   412 
 413 
In lieu of evidence from the literature, it is difficult to recommend or 414 
dissuade the clinical use of electrophysical agents as the sole 415 
intervention in LE. We contend that these treatments should be 416 
considered adjunctive treatments, largely to target the pain system to 417 
allow optimal, pain-free tendon loading. Further research regarding 418 
the effects of electrotherapy on accelerated and long-term healing of 419 
tendon is necessary. 420 
 421 
 422 
Manual therapy  423 
There is some evidence, albeit low level, of positive initial effects of 424 
several manipulative therapy techniques for pain relief and restoration 425 
of function when compared to control interventions.[55, 74, 105-107] 426 
It is hypothesised that the manipulation induced analgesia is primarily 427 
mediated via non-opioid, descending pain inhibitory mechanisms.[55, 428 
75, 107, 108] Soft tissue manipulations in the form of transverse 429 
frictions and Mill’s manipulations have been advocated for targeting 430 
the local tendon pathology, but results of clinical trials have not 431 
supported their use when compared to exercise [109], or corticosteroid 432 
injection. [110] No firm conclusions were made regarding use of 433 
orthotic devices for LE by two systematic reviews [111, 112] while a 434 
third reported an early positive, but inconclusive effect.[113]  435 
 436 
Exercise  437 
The effect of exercise training on stimulating tendon remodelling and 438 
producing muscular adaptive responses has been clearly 439 
documented.[26, 29, 30]  Thus, there exists a rationale for use of 440 
exercise to address two characteristic impairments in LE as outlined in 441 
Figure 1. In addition, exercise may have local analgesic effects, as 442 
observed following specific therapeutic exercise in chronic neck pain 443 
patients.[114]  444 
 445 
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Surprisingly, few studies have investigated the effect of therapeutic 446 
exercise as the sole treatment of LE compared to a control or no 447 
intervention.[111] Positive benefits after concluding an eight week 448 
exercise program were demonstrated in a chronic LE population, who 449 
had high baseline pain (73/100mm on VAS), and had failed other 450 
conservative treatments including corticosteroid injection.[115] On 451 
following a similar group of patients (Exercise N=12, Ultrasound N = 452 
11) for an average 36 months, these researchers showed that compared 453 
to an ultrasound treatment, exercise resulted in fewer medical 454 
consultations, less surgery (RR: 0.18 (95% CI: 0.03 to 1.33); NNT: 3) 455 
and 586 fewer sick days.[116] In another randomised controlled trial, 456 
the supervised exercise program produced the largest reduction of 457 
pain and improvement in function at all time points in the 6 month 458 
follow-up period, compared to Biopton light and soft tissue frictions 459 
with elbow manipulation.[109]  460 
 461 
The most effective exercise protocols in treating LE are not clearly 462 
established.[117, 118] The successful program utilised by Pienimaki 463 
et al (1996) comprised a combination of exercise modes - isometric 464 
and isotonic forearm exercises, forearm stretches and in the final 465 
stages functional exercises including gripping and manipulation tasks.  466 
Alizedehkhaiyat et al (2007) assert that a comprehensive rehabilitation 467 
program may be necessary to address the widespread upper limb 468 
weakness and changes in muscle activity found in LE.[72] Retraining 469 
of the functional task of gripping using a more efficient, slightly 470 
extended wrist posture may need to be factored into the design of 471 
rehabilitation programs.[67] Recently, there has been an increased 472 
emphasis placed on the role of isolated eccentric strengthening 473 
exercises for LE, modelling the apparently successful use of such 474 
exercise for lower limb tendinopathies.[119, 120] However, a recent 475 
systematic review concluded that there is currently insufficient 476 
evidence to support eccentric over concentric exercise for LE.[121] 477 
The intensity and frequency of tendon loading are also important 478 
variables, and should be attempted to be matched to the stage and 479 
reversibility of tendon pathology.[22] The pain system must be 480 
acknowledged to avoid peripheral nociceptive input reinforcing the 481 
hyperalgesic state.  Reduction of load may be necessary in the early 482 
phases of rehabilitation through avoidance of aggravating activities. 483 
 484 
Given hypotheses concerning stress-shielding [27, 36, 37] and the role 485 
of compressive forces in the aetiology of insertional tendinopathies 486 
[21, 38, 39], further research is necessary to determine the most 487 
efficient positions and exercises for tendon loading in LE. Greater 488 
success has been demonstrated for insertional Achilles tendinopathy 489 
with restriction of eccentric exercise to avoid full dorsiflexion.[122] 490 
As elbow extension has been found to be a more provocative position 491 
for gripping in LE [123], likely due to compressive forces at insertion, 492 
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we recommend that exercise of the wrist extensors be commenced in a 493 
flexed elbow position. 494 
 495 
Multimodal management  496 
Given the complexity of the pathophysiology of LE and the 497 
heterogeneity of clinical presentation, we propose a multimodal 498 
approach to management of this condition. Multimodal programs are 499 
recommended in other chronic musculoskeletal conditions [124] and 500 
have been studied in a number of randomised controlled trials of 501 
LE.[11, 92] The physiotherapy program utilised by Bisset et al (1996), 502 
combining concentric, eccentric and isometric exercise with 503 
‘Mobilisation with Movement’ manipulation techniques to the elbow, 504 
has shown positive results. It was superior to ‘wait and see’ at 6 weeks 505 
(RR: 2.44 (95% CI: 1.55 to 3.85); NNT: 3) and to corticosteroid 506 
injection at 26 weeks (RR: 1.88 (95% CI: 1.41 to 2.5); NNT: 2).[11]  507 
Other studies utilising exercise, ultrasound and friction massage have 508 
not found significant benefits over a wait and see approach.[92] In 509 
clinical practice, injections are commonly prescribed in conjunction 510 
with active exercise. Comparison of corticosteroid injection alone or 511 
combined with a progressive exercise program has only been made in 512 
one short-term study [125], but it suffered from a high drop out rate 513 
and was unable to support or refute the combined approach.  514 
 515 
 516 
CONCLUSION  517 
A new model of the pathophysiology of LE is presented, integrating 518 
local tendon pathology, pain system changes and motor impairment. 519 
This model encompasses an understanding that individual patients 520 
may present with relatively different contributions of local tendon 521 
pathology along with pain and motor system impairments. 522 
Importantly, it is our contention that to optimally manage each patient 523 
the clinician should consider this relativity. It must be appreciated that 524 
this model is conceptual in nature and reductionist by definition, but 525 
with capacity for development as new knowledge emerges. 526 
Furthermore, it may be seen as a precursor stage to the development 527 
of clinical prediction rules, classification and subgrouping studies as 528 
has occurred for other musculoskeletal conditions, albeit spinal. [126-529 
129]  530 
 531 
532 
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 962 
LEGEND TO FIGURES 963 
 964 
 965 
Figure 1: A new model of lateral epicondylalgia emphasising its 966 
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SUMMARY BOXES 972 
 973 
What is already known on this topic 974 
• Tendinopathies appear to share similar pathological features. 975 
• Lateral epicondylalgia can be challenging to treat with many 976 
treatment options available to the clinician  977 
 978 
What this study adds 979 
• An appreciation of the heterogenous clinical presentation of lateral 980 
epicondylalgia  981 
• A model that conceptualises lateral epicondylalgia as involving 982 
local tendon pathology, abnormal pain processing and motor 983 
system impairments  984 
• A rationale for physical interventions to be customised to each 985 
individual patient on the basis of proportional representation of 986 
local tendon, pain and motor deficits in the patient’s clinical 987 
presentation. 988 
• Multi-modal management approaches may offer practitioners 989 
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